Policy Utility and Empirical Analysis on the Coupling Development of Bio-Pharmaceutical Industry and New Enterprises Based on NB Statistical Model and Bayesian Probability

Zhewen Zhang; Xinyan Jiang; Wanchen Yao; Chenqi Li; Zihao Ye; Sijing Huang

doi:10.62051/ijgem.v8n2.11

Authors

Zhewen Zhang
Xinyan Jiang
Wanchen Yao
Chenqi Li
Zihao Ye
Sijing Huang

DOI:

https://doi.org/10.62051/ijgem.v8n2.11

Keywords:

Bayesian model, Biomedical industry, Policy effectiveness, NB statistical model

Abstract

Recent advances in life sciences and biotechnology have driven a new technological revolution, positioning the biopharmaceutical industry as a global leader. However, China’s biomedical technology still lags behind international standards. To capitalize on global biotechnology opportunities and enhance competitiveness, this study employs Bayesian model averaging to account for uncertainty, predict outcomes, and identify key influencing factors. Notably, China’s biopharmaceutical industry shows significant agglomeration, but domestic industrial division of labor remains weak, highlighting the need to strengthen and optimize industrial chain coordination.

Downloads

Download data is not yet available.

References

[1] Antimo Gioiello*, Alessandro Piccinno, Anna Maria Lozza, and Bruno Cerra. The Medicinal Chemistry in the Era of Machines and Automation:Recent Advances in Continuous Flow Technology [J]. Med. Chem. 2020, 63, 13, 6624-6647. https://doi.org/10.1021/acs.jmedchem.9b01956

[2] Anita Chen Marshall. Traditional Chinese Medicine and Clinical Pharmacology [J]. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. 2020 Mar 2: 455-482. https://doi: 10.1007/978-3-319-68864-0_ 60

[3] CN Fokunang, V Ndikum, [...], and Kamsu-Kom. Traditional Medicine: Past, Present and Future Research and Development Prospects and Integration in the National Health System of Cameroon [J]. Afr J Tradit Complement Altern Med. 2011; 8(3): 284-295. https://doi:10.4314/aitcam.v813.65276

[4] Lin, A.X., Chan, G., Hu, Y. et al. Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions [J]. Chin Med 13, 9 (2018). https://doi.org/10.1186/s13020-018-0167-z

[5] Mayara C S Barcelos, Fernanda B Lupki, Gabriela A Campolina, David Lee Nelson, Gustavo Molina, The colors of biotechnology: general overview and developments of white, green and blue areas, FEMS Microbiology Letters, Volume 365, Issue 21, November 2018, fny239, https://doi.org/10.1093/femsle/fny239

[6] Powell, Walter W. Inter-Organizational Collaboration in the Biotechnology Industry [J]. Journal of Institutional and Theoretical Economics (JITE) 152, no. 1 (1996): 197–215. http://www.jstor.org/stable/40751919.

[7] Dr Arun Bhatt. Evolution of Clinical Research: A History Before and Beyond James Lind [J]. Perspect Clin Res. 2010 Jan-Mar; 1(1): 6-10.

[8] David J. Spiegelhalter, Laurence S. Freedman and Mahesh K. B. Parmar. Bayesian Approaches to Randomized Trials [J]. Journal of the Royal Statistical Society. Series A (Statistics in Society)Vol. 157, No. 3 (1994), pp. 357-416 (60 pages).

[9] Simon Jackman. Bayesian analysis for political research [J]. Annual Review of PoliticalScience. Vol.7:483-505. https://doi.org/10.1146/annurev.polisci.7.012003.104706

[10] Nilsen, P.Making sense of implementation theories, models and frameworks. ImplementationSci10, 53(2015). https://doi.org/10.1186/s13012-015-0242-0

[11] Patrick Beer and Regina H. Mulder. The Effects of Technological Developments on Work and Their Implications for Continuous Vocational Education and Training: A Systematic Review [J]. Front Psychol.2020; 11: 918. Published online 2020 May 8. https://doi:10.3389/fpsyg.2020.00918

[12] Li Yixue. Problems and Countermeasures of Industrial Technology Progress in China [J]. managerialworld. 1999(01):139-143. https://doi:10.19744/j.cnki.11-1235/f.1999.01.015.

[13] Söderholm, P. The green economy transition: the challenges of technological change for sustainability [J]. Sustain Earth 3, 6 (2020). https://doi:org/10.1186/s42055-020-00029-y

[14] Zhang Ji, Shi Zhanzhong. Research on the effectiveness of policies in the medical device industry-An empirical study based on the return on investment of listed companies [J]. China Science and Technology Forum. 2014(6):51-55. https://doi:10.3969/j.issn.1002-6711.2014.06.009.

[15] Chu Shuzhen and Zhu Xuan. Research on the performance evaluation of China's pharmaceutical industry policy innovation based on Malmquist index [J]. China Health Statistics, 2015, 32(6):1014-1016